Site Members can sign up for company wide alerts
Investigation Overview
Jan. 29, 2013 (Shareholders Foundation) -- An investigation on behalf of current long term investors in shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) was announced concerning whether certain officers and directors of Raptor Pharmaceutical Corp. breached their fiduciary duties by paying certain top officials at Raptor Pharmaceutical excessive compensation. The investigation by a ...
You must register (for free) or login to view the entire investigation.